Riskpilot← Back to searchSign inGet full accessValVive AB
ABActiveOrg 5591401129Tallvägen 10Hospital activities · NACE 8610Est. 20171 employees
Revenue 2024
SEK 803K
+6% vs 2023
EBITDA margin
81.8%
+52% vs 2023
Equity ratio
91.3%
Financial strength
Net profit 2024
SEK 1,4M
+276% vs 2023
| Revenue | SEK 803K | +6% |
| EBITDA | SEK 657K | +52% |
| Net profit | SEK 1,4M | +276% |
| Total assets | SEK 5,8M | +35% |
| Equity | SEK 5,3M | +36% |
| Employees | 1 | — |
Legal name
ValVive AB
Org number
5591401129
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
18 december 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultverksamhet inom hälso- och sjukvård. Köp och försäljning av värdepapper. Fövärvning och förvaltning av fastigheter. Forskning, föreläsning och utbildning inom medicin. Framställning av litteratur samt idka därmed förenlig verksamhet.
Address
Tallvägen 10
Email
david.valijani@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 633 | 643 | 591 | 755 | 803 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 389 | 235 | 485 | 433 | 657 |
| Depreciation & amort. | −0 | −0 | −0 | −6 | −19 |
| EBIT | 1 389 | 235 | 485 | 427 | 638 |
| Net financials | −3 | −6 | −3 | 46 | 903 |
| Profit before tax | 1 386 | 229 | 482 | 473 | 1 541 |
| Tax | −299 | −49 | −102 | −99 | −135 |
| Net profit | 1 087 | 180 | 380 | 374 | 1 406 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 557 | 3 546 | 3 796 | 4 301 | 5 795 |
| Equity | 3 484 | 3 130 | 3 509 | 3 883 | 5 289 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 073 | 416 | 286 | 418 | 505 |
| Total debt | 1 073 | 416 | 286 | 418 | 505 |
EBITDA margin
81.8%
This company
15.8%
Market median
+418% vs market
20202024
Equity ratio
91.3%
This company
38.2%
Market median
+139% vs market
20202024
Return on equity
26.6%
This company
18.4%
Market median
+45% vs market
20202024
Net profit margin
175.1%
This company
8.1%
Market median
+2062% vs market
20202024
Asset turnover
0.14×
This company
1.12×
Market median
-88% vs market
20202024
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ValVive AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| David Valijani | Board of Directors | 0 companies |
| Davood Valijani | Deputy Board Member | 0 companies |